Navigation Links
TorreyPines Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference
Date:11/27/2007

LA JOLLA, Calif., Nov. 27 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that Dr. Michael Murphy, Chief Medical Officer of TorreyPines, will present at the BMO Capital Markets Focus on Healthcare Conference in New York on Tuesday, December 4th at 3:00 p.m., eastern.

A webcast of Dr. Murphy's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer's disease. Further information is available at http://www.torreypinestherapeutics.com.


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. TorreyPines Therapeutics to Present at the JMP Securities Healthcare Focus Conference
2. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Prime Therapeutics Receives TIPPS Certification
5. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
6. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
7. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
10. Prime Therapeutics Announces URAC Accreditation
11. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 3Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 4Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 2Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 3Health News:Trust Us, Kids ... We've Got You Covered 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Tess Daly Supports Hallmark's Breast Cancer Campaign 2Health News:Tess Daly Supports Hallmark's Breast Cancer Campaign 3
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 1Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 2Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 3Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 4Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 1Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 2Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 3VetsFirst Established by United Spinal Association 3A First and Only Organization to Offer Full Membership to All Disabled Veterans Their Dependents 60326 1VetsFirst Established by United Spinal Association 3A First and Only Organization to Offer Full Membership to All Disabled Veterans Their Dependents 60326 2